|1||Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
文獻出處：Cancer Gene Thera. 7; 1481-1490 (2000)
|2||A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
文獻出處：Clin Cancer Res. 20; 6079-6086 (2006)